{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:15:21Z","timestamp":1794006921135,"version":"4.8.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660139"],"award-info":[{"award-number":["81660139"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1038\/s41371-019-0291-y","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T14:10:42Z","timestamp":1575295842000},"page":"633-640","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mild primary aldosteronism (PA) followed by overt PA are possibly the most common forms of low renin hypertension: a single-center retrospective study"],"prefix":"10.1038","volume":"34","author":[{"given":"Qin","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1505-8566","authenticated-orcid":false,"given":"Nanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulalibieke","family":"Heizhati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"291_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0002-9343(73)90128-9","volume":"55","author":"JH Laragh","year":"1973","unstructured":"Laragh JH. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med. 1973;55:261\u201374.","journal-title":"Am J Med"},{"key":"291_CR2","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/0002-8703(79)90292-8","volume":"98","author":"A Ganguly","year":"1979","unstructured":"Ganguly A, Weinberger MH. Low renin hypertension: a current review of definitions and controversies. Am Heart J. 1979;98:642\u201352.","journal-title":"Am Heart J"},{"key":"291_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.tem.2005.02.004","volume":"16","author":"RD Gordon","year":"2005","unstructured":"Gordon RD, Laragh JH, Funder JW. Low renin hypertensive states: perspectives, unsolved problems, future research. Trends Endocrinol Metab. 2005;16:108\u201313.","journal-title":"Trends Endocrinol Metab"},{"key":"291_CR4","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69:1811\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"291_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-0031-1295438","volume":"44","author":"A Hannemann","year":"2012","unstructured":"Hannemann A, Wallaschofski K. Prevalence of primary aldosteronism in patient cohort and in population-based studies: a review of the current literature. Horm Metabol Res. 2012;44:157\u201362.","journal-title":"Horm Metabol Res"},{"key":"291_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1365-2265.2007.02898.x","volume":"67","author":"P Mulatero","year":"2007","unstructured":"Mulatero P, Verhovez A, Morello F, Veglio F. Diagnosis and treatment of low-renin hypertension. Clin Endocrinol. 2007;67:324\u201334.","journal-title":"Clin Endocrinol"},{"key":"291_CR7","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/ajh\/hpt091","volume":"26","author":"EV Adlin","year":"2013","unstructured":"Adlin EV, Braitman LE, Vasan RS. Bimodal aldosterone distribution in low-renin hypertension. Am J Hypertens. 2013;26:1076\u201385.","journal-title":"Am J Hypertens"},{"key":"291_CR8","doi-asserted-by":"publisher","first-page":"E546","DOI":"10.3390\/ijms19020546","volume":"19","author":"R Baudrand","year":"2018","unstructured":"Baudrand R, Vaidya A. The low-renin hypertension phenotype: genetics and the role of the mineralocorticoid receptor. Int J Mol Sci. 2018;19:E546.","journal-title":"Int J Mol Sci"},{"key":"291_CR9","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"291_CR10","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1210\/jc.2013-2805","volume":"98","author":"P Mulatero","year":"2013","unstructured":"Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, et al. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013;98:4826\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"291_CR11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","volume":"71","author":"Y Ohno","year":"2018","unstructured":"Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, et al. Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension. 2018;71:530\u20137.","journal-title":"Hypertension"},{"key":"291_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.tem.2008.01.005","volume":"19","author":"G Giacchetti","year":"2008","unstructured":"Giacchetti G, Mulatero P, Mantero F, Veglio F, Boscaro M, Fallo F. Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis. Trends Endocrinol Metab. 2008;19:104\u20138.","journal-title":"Trends Endocrinol Metab"},{"key":"291_CR13","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","volume":"69","author":"R Baudrand","year":"2017","unstructured":"Baudrand R, Guarda FJ, Fardella C, Hundemer G, Brown J, Williams G, et al. Continuum of renin-independent aldosteronism in normotension. Hypertension. 2017;69:950\u20136.","journal-title":"Hypertension"},{"key":"291_CR14","doi-asserted-by":"publisher","first-page":"R191","DOI":"10.1530\/EJE-14-0537","volume":"172","author":"G Piaditis","year":"2015","unstructured":"Piaditis G, Markou A, Papanastasiou L, Androulakis II, Kaltsas G. Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension. Eur J Endocrinol. 2015;172:R191\u2013203.","journal-title":"Eur J Endocrinol"},{"key":"291_CR15","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","volume":"371","author":"S Douma","year":"2008","unstructured":"Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008;371:1921\u20136.","journal-title":"Lancet"},{"key":"291_CR16","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1046\/j.1365-2168.2002.02261.x","volume":"89","author":"M Sywak","year":"2002","unstructured":"Sywak M, Pasieka JL. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg. 2002;89:1587\u201393.","journal-title":"Br J Surg"},{"key":"291_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep32103","volume":"6","author":"VC Wu","year":"2016","unstructured":"Wu VC, Wang SM, Chang CH, Hu YH, Lin LY, Lin YH, et al. Long term outcome of Aldosteronism after target treatments. Sci Rep. 2016;6:32103.","journal-title":"Sci Rep"},{"key":"291_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","volume":"217","author":"M Stowasser","year":"2004","unstructured":"Stowasser M, Gordon RD. Primary aldosteronism\u2013careful investigation is essential and rewarding. Mol Cell Endocrinol. 2004;217:33\u20139.","journal-title":"Mol Cell Endocrinol"},{"key":"291_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","volume":"42","author":"L Mosso","year":"2003","unstructured":"Mosso L, Carvajal C, Gonzalez A, Barraza A, Avila F, Montero J, et al. Primary aldosteronism and hypertensive disease. Hypertension. 2003;42:161\u20135.","journal-title":"Hypertension"},{"key":"291_CR20","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"291_CR21","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"291_CR22","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1210\/jc.2016-1472","volume":"101","author":"SC K\u00e4yser","year":"2016","unstructured":"K\u00e4yser SC, Dekkers T, Groenewoud HJ, van der Wilt GJ, Carel Bakx J, van der Wel MC, et al. Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis. J Clin Endocrinol Metab. 2016;101:2826\u201335.","journal-title":"J Clin Endocrinol Metab"},{"key":"291_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/jhh.2015.21","volume":"30","author":"Q Luo","year":"2016","unstructured":"Luo Q, Li NF, Yao XG, Zhang DL, Abulikemu SF, Chang GJ, et al. Potential effects of age on screening for primary aldosteronism. J Hum Hypertens. 2016;30:53\u201361.","journal-title":"J Hum Hypertens"},{"key":"291_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","volume":"63","author":"GP Rossi","year":"2014","unstructured":"Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014;63:151\u201360.","journal-title":"Hypertension"},{"key":"291_CR25","doi-asserted-by":"crossref","unstructured":"The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413\u201346.","DOI":"10.1001\/archinte.157.21.2413"},{"key":"291_CR26","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1210\/jc.2018-01394","volume":"103","author":"M Stowasser","year":"2018","unstructured":"Stowasser M, Ahmed AH, Cowley D, Wolley M, Guo Z, McWhinney BC, et al. Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 2018;103:4113\u201324.","journal-title":"J Clin Endocrinol Metab"},{"key":"291_CR27","doi-asserted-by":"publisher","first-page":"630","DOI":"10.7326\/M17-0882","volume":"167","author":"JM Brown","year":"2017","unstructured":"Brown JM, Robinson-Cohen C, Luque-Fernandez MA, Allison MA, Baudrand R, Ix JH, et al. The spectrum of subclinical primary aldosteronism and incident hypertension: a Cohort Study. Ann Intern Med. 2017;167:630\u201341.","journal-title":"Ann Intern Med"},{"key":"291_CR28","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1210\/jc.2012-3353","volume":"98","author":"A Markou","year":"2013","unstructured":"Markou A, Pappa T, Kaltsas G, Gouli A, Mitsakis K, Tsounas P, et al. Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension. J Clin Endocrinol Metab. 2013;98:1409\u201316.","journal-title":"J Clin Endocrinol Metab"},{"key":"291_CR29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1530\/EJE-17-0978","volume":"178","author":"DA Heinrich","year":"2018","unstructured":"Heinrich DA, Adolf C, Rump LC, Quack I, Quinkler M, Hahner S, et al. Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms. Eur J Endocrinol. 2018;178:605\u201311.","journal-title":"Eur J Endocrinol"},{"key":"291_CR30","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1210\/js.2017-00134","volume":"1","author":"K Omata","year":"2017","unstructured":"Omata K, Anand SK, Hovelson DH, Liu CJ, Yamazaki Y, Nakamura Y, et al. Aldosterone-producing cell clusters frequently harbor somatic mutations and accumulate with age in normal adrenals. J Endocr Soc. 2017;1:787\u201399.","journal-title":"J Endocr Soc"},{"key":"291_CR31","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1055\/s-0043-122394","volume":"49","author":"K Omata","year":"2017","unstructured":"Omata K, Tomlins SA, Rainey WE. Aldosterone-producing cell clusters in normal and pathological states. Horm Metab Res. 2017;49:951\u20136.","journal-title":"Horm Metab Res"},{"key":"291_CR32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1530\/EJE-14-1013","volume":"172","author":"M Weigel","year":"2015","unstructured":"Weigel M, Riester A, Hanslik G, Lang K, Willenberg HS, Endres S, et al. Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism. Eur J Endocrinol. 2015;172:443\u201350.","journal-title":"Eur J Endocrinol"},{"key":"291_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1507\/endocrj.EJ16-0337","volume":"64","author":"R Hayashi","year":"2017","unstructured":"Hayashi R, Tamada D, Murata M, Mukai K, Kitamura T, Otsuki M, et al. Saline Infusion Test highly associated with the incidence of cardio-and cerebrovascular events in primary aldosteronism. Endocr J. 2017;64:507\u201313.","journal-title":"Endocr J"},{"key":"291_CR34","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/ndt\/gfs587","volume":"28","author":"Y Ori","year":"2013","unstructured":"Ori Y, Chagnac A, Korzets A, Zingerman B, Herman-Edelstein M, Bergman M, et al. Regression of left ventricular hypertrophy in patients with primary aldosteronism\/low-renin hypertension on low-dose spironolactone. Nephrol Dial Transpl. 2013;28:1787\u201393.","journal-title":"Nephrol Dial Transpl"},{"key":"291_CR35","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1097\/HJH.0000000000001251","volume":"35","author":"M Murata","year":"2017","unstructured":"Murata M, Kitamura T, Tamada D, Mukai K, Kurebayashi S, Yamamoto T, et al. Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism. J Hypertens. 2017;35:1079\u201385.","journal-title":"J Hypertens"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41371-019-0291-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41371-019-0291-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41371-019-0291-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:24:32Z","timestamp":1684617872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-019-0291-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["291"],"URL":"https:\/\/doi.org\/10.1038\/s41371-019-0291-y","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]},"assertion":[{"value":"17 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study retrospectively analyzed data generated in a clinical process.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human participants and\/or animals"}},{"value":"This was a retrospective data analysis that did not require informed consent from participants. The ethical committee of our hospital approved the study design and data analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}